<http://webisa.webdatacommons.org/302350153>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/302350153>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<in-pharmatechnologist.com> .
<http://webisa.webdatacommons.org/302350153>	<http://www.w3.org/ns/prov#value>	"Pharming has bought patents and licenses on various products and technologies, including the production and purification of recombinant human fibrinogen and recombinant tissue sealant compositions.After exiting from the transgenic production business, PPL made a short-lived effort to reposition itself as a product development company focusing on fibrinogen, but was unable to drum up interest from" .
<http://webisa.webdatacommons.org/prov/400020367>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/302350153> .
<http://webisa.webdatacommons.org/prov/220739118>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/302350153> .